Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Non-Current Assets (2019 - 2025)

Silo Pharma (SILO) has disclosed Non-Current Assets for 7 consecutive years, with $217375.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 27.63% to $217375.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217375.0 through Dec 2025, down 27.63% year-over-year, with the annual reading at $217375.0 for FY2025, 27.63% down from the prior year.
  • Non-Current Assets hit $217375.0 in Q4 2025 for Silo Pharma, down from $220312.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $309464.0 in Q2 2024 to a low of $19375.0 in Q1 2021.
  • Historically, Non-Current Assets has averaged $144384.3 across 5 years, with a median of $92724.0 in 2021.
  • Biggest five-year swings in Non-Current Assets: soared 403.71% in 2022 and later crashed 51.53% in 2023.
  • Year by year, Non-Current Assets stood at $87869.0 in 2021, then decreased by 19.4% to $70821.0 in 2022, then dropped by 8.24% to $64983.0 in 2023, then skyrocketed by 362.21% to $300360.0 in 2024, then fell by 27.63% to $217375.0 in 2025.
  • Business Quant data shows Non-Current Assets for SILO at $217375.0 in Q4 2025, $220312.0 in Q3 2025, and $279476.0 in Q2 2025.